Clinical Trials Logo

Clinical Trial Summary

Reducing or suspending the increase of the infarcted core, i.e., "freezing" the ischemic penumbra, may help improve the efficacy of mechanical thrombectomy. Hypothermia effectively reduces the metabolic level of brain tissue, may prolong the time window for recanalization therapy, and its multi-target therapeutic effect make it one of the most promising neuro-protection approach. In recent years, hypothermia has been increasingly used to treat acute ischemic stroke. However, its role in acute ischemic stroke is unclear. The objective of this trial is to investigate whether hypothermia combined with endovascular thrombectomy could add additional benefit without increasing the risk of adverse events such as pneumonia, intracerebral hemorrhage, and mortality.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06109376
Study type Interventional
Source Xinqiao Hospital of Chongqing
Contact Guangxiong Yuan, M.S.
Phone 18973223018
Email yuanguangxiong74@163.com
Status Not yet recruiting
Phase N/A
Start date December 1, 2023
Completion date March 31, 2027